Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 1143-1147, June 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hacker, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hacker, B.

Modulation of Transfer RNA-methylating Enzyme Activities in Murine Leukemic Cells1

Bruce Hacker

Department of Pharmacology and Toxicology, Division of Oncology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642

The activities of those processing enzymes responsible for the methylation of tRNA in murine leukemic cells were compared in sublines selected for their sensitivity and resistance to various antineoplastic agents. With one exception, the capacity and extent of tRNA methylation were elevated in the drug-resistant sublines. The following order of activities was demonstrated: L1210/cytoxan > L1210/cytosine arabinoside > L1210; L5178Y/actinomycin D > L5178Y; L5178YF/L-asparaginase > L5178YF; but P388 > P388/vincristine. These results suggest that the methylation of tRNA in murine leukemic cells may be modulated in cells with drug-resistant properties.

1 This investigation was supported by Grant CA-11198 from the National Cancer Institute, General Research Support Grant RR-05403 from the USPHS, Grant IN-18M from the American Cancer Society, and USPHS Grant CA-12269 from the National Cancer Institute.

Received 5/ 4/71. Accepted 2/25/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.